Back to top
more

Option Care Health (OPCH)

(Delayed Data from NSDQ)

$29.61 USD

29.61
1,759,663

+0.32 (1.09%)

Updated Apr 26, 2024 03:59 PM ET

After-Market: $29.61 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (151 out of 252)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

Option Care (OPCH) is on the Move, Here's Why the Trend Could be Sustainable

Option Care (OPCH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Option Care (OPCH) Q3 Earnings and Revenues Surpass Estimates

Option Care (OPCH) delivered earnings and revenue surprises of 11.11% and 1.01%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

New Strong Buy Stocks for November 3rd

CNX, DOW, SNDR, HLIT, and OPCH have been added to the Zacks Rank #1 (Strong Buy) List on November 3, 2021.

Option Care (OPCH) Earnings Expected to Grow: Should You Buy?

Option Care (OPCH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Riya Anand headshot

3 High-Potential MedTech Stocks With More Than 50% Growth YTD

Stocks like West Pharmaceuticals Services (WST), Maravai LifeSciences (MRVI) and Option Care Health (OPCH) have gained stupendously year to date.

Option Care (OPCH) Upgraded to Strong Buy: What Does It Mean for the Stock?

Option Care (OPCH) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Top Ranked Momentum Stocks to Buy for September 14th

RRC, OPCH, CNQ, and ARES made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 14, 2021.

What Makes Option Care (OPCH) a Good Fit for "Trend Investing"

If you are looking for stocks that are well positioned to maintain their recent uptrend, Option Care (OPCH) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Urmimala Biswas headshot

3 MedTech Sectors Benefiting Despite COVID-19 Resurgence

Here we discuss three major subsectors of MedTech and some of their constituent stocks for which COVID-19 has opened up enormous growth prospects.

Can Option Care (OPCH) Run Higher on Rising Earnings Estimates?

Option Care (OPCH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Recent Price Trend in Option Care (OPCH) is Your Friend, Here's Why

If you are looking for stocks that are well positioned to maintain their recent uptrend, Option Care (OPCH) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

New Strong Buy Stocks for August 16th

CVLG, DDS, MHO, OPCH, and TUP have been added to the Zacks Rank #1 (Strong Buy) List on August 16, 2021.

Option Care (OPCH) Beats Q2 Earnings and Revenue Estimates

Option Care (OPCH) delivered earnings and revenue surprises of 125.00% and 9.19%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Option Care (OPCH) Reports Next Week: Wall Street Expects Earnings Growth

Option Care (OPCH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Option Care (OPCH) Reports Q1 Loss, Tops Revenue Estimates

Option Care (OPCH) delivered earnings and revenue surprises of -200.00% and 0.80%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Is Option Care Health (OPCH) Outperforming Other Medical Stocks This Year?

Is (OPCH) Outperforming Other Medical Stocks This Year?

Option Care (OPCH) Q4 Earnings and Revenues Beat Estimates

Option Care (OPCH) delivered earnings and revenue surprises of 42.86% and 0.49%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Option Care (OPCH) Dips More Than Broader Markets: What You Should Know

Option Care (OPCH) closed at $19.54 in the latest trading session, marking a -1.19% move from the prior day.

What's in Store for Fulgent Genetics (FLGT) in Q4 Earnings?

We expect strong demand for Fulgent Genetics' (FLGT) end-to-end tests for COVID-19 to have continued through the fourth quarter.

DENTSPLY SIRONA (XRAY) to Post Q4 Earnings: What's in Store?

DENTSPLY SIRONA's (XRAY) fourth-quarter results are likely to reflect weak segmental performance.

Option Care (OPCH) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Option Care (OPCH) closed at $18.97, marking a +0.58% move from the previous day.

Is Option Care Health (OPCH) Outperforming Other Medical Stocks This Year?

Is (OPCH) Outperforming Other Medical Stocks This Year?

Owens & Minor (OMI) to Report Q4 Earnings: What's in Store?

We expect the strength in demand for Owens & Minor's (OMI) PPEs to have continued through the fourth quarter.

Option Care (OPCH) Gains As Market Dips: What You Should Know

Option Care (OPCH) closed the most recent trading day at $19.86, moving +0.2% from the previous trading session.

Lower Bulk Purchases May Weigh on Medtronic (MDT) Q3 Earnings

Medtronic's (MDT) diabetes care, robotics surgery and neuromodulation lines are expected to have performed well in Q3.